These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 36469491

  • 1. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
    Nakahama T, Kawahara Y.
    Int Immunol; 2023 Mar 14; 35(3):123-133. PubMed ID: 36469491
    [Abstract] [Full Text] [Related]

  • 2. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
    Nakahama T, Kawahara Y.
    Int J Mol Sci; 2021 Oct 23; 22(21):. PubMed ID: 34768866
    [Abstract] [Full Text] [Related]

  • 3. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation.
    de Reuver R, Dierick E, Wiernicki B, Staes K, Seys L, De Meester E, Muyldermans T, Botzki A, Lambrecht BN, Van Nieuwerburgh F, Vandenabeele P, Maelfait J.
    Cell Rep; 2021 Aug 10; 36(6):109500. PubMed ID: 34380029
    [Abstract] [Full Text] [Related]

  • 4. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
    Kim JI, Nakahama T, Yamasaki R, Costa Cruz PH, Vongpipatana T, Inoue M, Kanou N, Xing Y, Todo H, Shibuya T, Kato Y, Kawahara Y.
    PLoS Genet; 2021 May 10; 17(5):e1009516. PubMed ID: 33983932
    [Abstract] [Full Text] [Related]

  • 5. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
    Nakahama T, Kato Y, Shibuya T, Inoue M, Kim JI, Vongpipatana T, Todo H, Xing Y, Kawahara Y.
    Immunity; 2021 Sep 14; 54(9):1976-1988.e7. PubMed ID: 34525338
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms.
    Sun T, Yu Y, Wu X, Acevedo A, Luo JD, Wang J, Schneider WM, Hurwitz B, Rosenberg BR, Chung H, Rice CM.
    Proc Natl Acad Sci U S A; 2021 Mar 23; 118(12):. PubMed ID: 33723056
    [Abstract] [Full Text] [Related]

  • 14. ADAR1 Zα domain P195A mutation activates the MDA5-dependent RNA-sensing signaling pathway in brain without decreasing overall RNA editing.
    Guo X, Liu S, Sheng Y, Zenati M, Billiar T, Herbert A, Wang Q.
    Cell Rep; 2023 Jul 25; 42(7):112733. PubMed ID: 37421629
    [Abstract] [Full Text] [Related]

  • 15. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself.
    Liddicoat BJ, Piskol R, Chalk AM, Ramaswami G, Higuchi M, Hartner JC, Li JB, Seeburg PH, Walkley CR.
    Science; 2015 Sep 04; 349(6252):1115-20. PubMed ID: 26275108
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An Aicardi-Goutières Syndrome-Causative Point Mutation in Adar1 Gene Invokes Multiorgan Inflammation and Late-Onset Encephalopathy in Mice.
    Inoue M, Nakahama T, Yamasaki R, Shibuya T, Kim JI, Todo H, Xing Y, Kato Y, Morii E, Kawahara Y.
    J Immunol; 2021 Dec 15; 207(12):3016-3027. PubMed ID: 34772697
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.